“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” declares the author of today’s article of the five Buy-rated stocks trading under $10 that he highlights. Among them are a late-stage pharmaceutical company focused on developing potential new therapies for cancer, a security technology company that provides email encryption and data loss prevention services, and a small-cap oilfield services play. For these five stocks, CLICK HERE.
These 5 Stocks Cost Little And Have “Mammoth Upside Potential”
Tags:Aggressive InvestorsBuy-Rated StocksData Loss Prevention InvestmentsPharmaceutical InvestmentsSecurity Technology InvestmentsSmall-CapsStock MarketStock PlaysTrading Under $10Upside Potential